Brain-Expressed X-linked (BEX) proteins in human cancers

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The Brain-Expressed X-linked (BEX) protein family, comprising BEX1-BEX5, is involved in neuronal development.
• Emerging evidence suggests BEX proteins play significant roles in various human cancers.

Purpose of the Study:

• To elucidate the distinct roles of BEX family members in cancer development and progression.
• To investigate the functional impact of BEX1, BEX2, and BEX3 in specific cancer types.

Main Methods:

• Analysis of BEX gene expression in patient cohorts with acute myeloid leukemia (AML), chronic myeloid leukemia (CML), breast cancer, and gliomas.
• Functional studies assessing the effects of BEX1, BEX2, and BEX3 on cell signaling pathways (e.g., NF-κB) and cellular processes (e.g., proliferation, tumor formation).
• Evaluation of BEX1's role in restoring drug response in resistant cancer cells.

Main Results:

• BEX1 expression is lost in AML and CML, and its restoration can re-sensitize cells to imatinib.
• BEX2 is overexpressed in breast cancer and gliomas, promoting NF-κB signaling and proliferation, thus acting as a tumor promoter.
• BEX3 overexpression inhibits tumor formation in breast cancer models, indicating a tumor-suppressive role.

Conclusions:

• BEX family proteins exhibit differential functions in cancer, with BEX1 and BEX3 acting as tumor suppressors.
• BEX2 functions as an oncogene, contributing to tumor progression in specific cancers.
• Further research is needed to define the roles of BEX4 and BEX5 in oncogenesis.